IRIS
LIAKOULI, Vasiliki
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.778
NA - Nord America 4.365
AS - Asia 2.993
SA - Sud America 675
Continente sconosciuto - Info sul continente non disponibili 231
AF - Africa 39
Totale 14.081
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.227
RU - Federazione Russa 4.093
SG - Singapore 1.064
IE - Irlanda 607
CN - Cina 595
HK - Hong Kong 579
BR - Brasile 565
VN - Vietnam 391
IT - Italia 373
GB - Regno Unito 253
KR - Corea 182
DE - Germania 157
GR - Grecia 113
CA - Canada 51
SE - Svezia 46
IN - India 43
AR - Argentina 42
UA - Ucraina 38
FR - Francia 28
ID - Indonesia 24
MX - Messico 23
BD - Bangladesh 21
TR - Turchia 20
EC - Ecuador 19
CO - Colombia 17
JP - Giappone 16
FI - Finlandia 13
ZA - Sudafrica 13
PY - Paraguay 12
CR - Costa Rica 10
IQ - Iraq 10
NL - Olanda 10
PK - Pakistan 10
TT - Trinidad e Tobago 10
UZ - Uzbekistan 8
AT - Austria 7
VE - Venezuela 7
ES - Italia 6
HN - Honduras 6
JM - Giamaica 6
SC - Seychelles 6
CL - Cile 5
MA - Marocco 5
NI - Nicaragua 5
PR - Porto Rico 5
SV - El Salvador 5
AL - Albania 4
BE - Belgio 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
IL - Israele 4
KE - Kenya 4
PE - Perù 4
PL - Polonia 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
EG - Egitto 3
GP - Guadalupe 3
GT - Guatemala 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
JO - Giordania 2
LV - Lettonia 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AO - Angola 1
BB - Barbados 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NO - Norvegia 1
PH - Filippine 1
RS - Serbia 1
TH - Thailandia 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 13.852
Salva come PNG Salva come JPEG
Città #
Moscow 1.377
Dublin 607
Hong Kong 573
Chicago 541
Santa Clara 513
Wilmington 441
Singapore 436
Falls Church 338
Ashburn 309
San Jose 297
Council Bluffs 263
Jacksonville 178
Seoul 177
Ho Chi Minh City 123
Beijing 122
Princeton 118
Roxbury 108
Chandler 103
Bremen 102
Hanoi 100
Medford 75
Hefei 71
Milan 67
Des Moines 41
Rome 38
Naples 37
Cambridge 36
São Paulo 36
Miano 32
Dallas 30
Los Angeles 27
Da Nang 24
North Bergen 21
Bengaluru 19
The Dalles 19
Rio de Janeiro 18
New York 17
Atlanta 15
Nanjing 15
Frankfurt am Main 14
Guangzhou 14
Belo Horizonte 13
Brasília 13
Ann Arbor 12
Jinan 12
Montreal 12
Curitiba 11
Guarulhos 11
Hải Dương 11
Caserta 10
Thái Bình 10
Boardman 9
Mexico City 9
Ottawa 9
Shanghai 9
Tianjin 9
Amsterdam 8
Biên Hòa 8
Hangzhou 8
Hebei 8
Munich 8
Phoenix 8
Salvador 8
Shenyang 8
Tashkent 8
Baghdad 7
Bologna 7
Haiphong 7
Johannesburg 7
Ningbo 7
San José 7
Thái Nguyên 7
Abbeville 6
Bắc Ninh 6
Changsha 6
Guayaquil 6
Houston 6
Kingston 6
Kunming 6
Phủ Lý 6
Santo André 6
Athens 5
Bagnoli Irpino 5
Bogotá 5
Campinas 5
Caxias do Sul 5
Chaguanas 5
Ciudad del Este 5
Dearborn 5
Falkenstein 5
Florence 5
Helsinki 5
Jakarta 5
Las Vegas 5
London 5
Lấp Vò 5
Managua 5
Marsico Nuovo 5
Natal 5
Nha Trang 5
Totale 7.922
Salva come PNG Salva come JPEG
Nome #
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 1.395
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 194
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population 159
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 158
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 149
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 143
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 143
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 141
. FRI0437 Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from SSC Patients Induces an Anti Angiogenetic Effect, when Co-Cultured with Endothelial Cells. 132
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 129
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 128
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 128
AB0226 Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC). 127
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 126
Association of FASG670A gene polymorphism with systemic sclerosis. 125
Angiogenic cytokines and growth factors in systemic sclerosis 124
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 124
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome 122
AB0244 Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 122
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 121
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 120
Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? 117
AI-Based HRCT Quantification in Connective Tissue Disease-Associated Interstitial Lung Disease 113
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 113
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 112
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 112
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 111
Modificazioni della nitrossido-sintasi neuronale (nNOS) nella cute dei pazienti con sclerosi sistemica (SSc). 109
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 108
AB0248 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 107
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 106
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 106
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 106
Interstitial lung disease in systemic sclerosis: current and future treatment 105
Cardiovascular disease in primary sjögren’s syndrome 105
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 103
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 103
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 103
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 102
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 102
IMPAIREMENT OF ENDOTHELIAL DIFFERENTIATION FROM MESENCHYMAL STEM CELLS (MSC) IN SYSTEMIC SCLEROSIS (SSC): A NEW TOOL IN PATHOGENETIC MECHANISM 101
Interleukin-33 and its receptor st2 may serve as 'alarmin' system of the progressing damage to the skin and visceral organs of systemic sclerosis (ssc) patients 101
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 99
Towards a consensus on the clinical applications and interpretations of the nailfold capillaroscopy standards in clinical practice: An initiative by the Egyptian Society of Microcirculation 98
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 98
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients 98
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 98
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 97
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 96
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 95
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy 95
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION 95
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: pathogenetic implication. 95
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 95
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis 95
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI) 95
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 94
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 94
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis 94
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies 94
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease 94
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 94
The Vessels Contribute to Fibrosis in Systemic Sclerosis 94
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease. 94
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 93
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine 93
Surface expression of fractalkine receptor (CX3CR1) on CD4+/CD28 T cells in RA patients and correlation with atherosclerotic damage 92
Development of a core domain set for nailfold capillaroscopy reporting 91
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 91
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 91
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 91
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus 91
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 90
Subclinical and clinical atherosclerosis in rheumatoid arthritis: Results from the 3-year, multicentre, prospective, observational GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 90
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 90
Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor 90
Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare 89
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 89
SAT0191 Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren's syndrome. 89
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 89
Virtual skin biopsy by optical coherence tomography: the first quantitative imaging biomarker for scleroderma 89
Cellular players in angiogenesis during the course of systemic sclerosis 88
Endothelial Progenitor Cells (EPC) characterization in systemic sclerosis (SSc) patients. 88
FAS -670 gene promoter polymorphism confers susceptibility to systemic sclerosis 88
Macitentan inhibits the transforming growth factor-βprofibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts. 88
Tocilizumab for the treatment of adult-onset Still's disease: results from a case series 87
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort 86
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 86
Methotrexate: an old new drug in autoimmune disease 86
SDF-1 expression in the skin of SSc patients. 85
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 85
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 84
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 84
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 84
Decreased expression of angiopoietin 1 on perivascular mesenchymalstemcells from SSc patients induces an anti angiogenic effect, when co-cultured with endothelial cells 84
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 83
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC) 83
Pigment epithelium derived factor secreted by ssc fibroblasts inhibits angio and vasculogenesis in vitro. 83
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 83
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients 82
Totale 11.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.144
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022867 0 0 0 0 322 30 24 25 43 30 84 309
2022/20231.336 206 85 308 14 138 37 0 27 503 2 5 11
2023/2024356 18 9 3 7 160 10 6 12 4 7 9 111
2024/20251.826 1 0 3 31 240 283 292 165 231 395 111 74
2025/20266.939 258 343 425 482 652 3.766 270 254 224 128 105 32
2026/20271.466 61 254 461 615 75 0 0 0 0 0 0 0
Totale 14.081